SpectraCure AB
SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical fibers; and disposable items comprising needles, optical fibers, and light-sensitive medication. The company was incorporated in 2003 and is based in Lund, Sweden.
SpectraCure AB (SPEC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.048x
Based on the latest financial reports, SpectraCure AB (SPEC) has a cash flow conversion efficiency ratio of -0.048x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-4.48 Million) by net assets (Skr93.55 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
SpectraCure AB - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how SpectraCure AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
SpectraCure AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SpectraCure AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Witbe Net SA
PA:ALWIT
|
0.366x |
|
Caely Holdings Bhd
KLSE:7154
|
-0.006x |
|
Suparma Tbk
JK:SPMA
|
0.049x |
|
i2S SA
PA:ALI2S
|
0.039x |
|
Polychem Indonesia Tbk
JK:ADMG
|
-0.015x |
|
Top Gum Industries Ltd
TA:TPGM
|
0.020x |
|
Tuktu Resources Ltd.
V:TUK
|
-0.001x |
|
Clientele
JSE:CLI
|
-0.059x |
Annual Cash Flow Conversion Efficiency for SpectraCure AB (2014–2025)
The table below shows the annual cash flow conversion efficiency of SpectraCure AB from 2014 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr93.55 Million | Skr-24.03 Million | -0.257x | -25.74% |
| 2024-12-31 | Skr106.86 Million | Skr-21.83 Million | -0.204x | -41.99% |
| 2023-12-31 | Skr129.86 Million | Skr-18.68 Million | -0.144x | +5.84% |
| 2022-12-31 | Skr150.30 Million | Skr-22.96 Million | -0.153x | -44.27% |
| 2021-12-31 | Skr175.68 Million | Skr-18.60 Million | -0.106x | -122.07% |
| 2020-12-31 | Skr197.22 Million | Skr-9.40 Million | -0.048x | +58.37% |
| 2019-12-31 | Skr87.78 Million | Skr-10.05 Million | -0.115x | +17.12% |
| 2018-12-31 | Skr64.92 Million | Skr-8.97 Million | -0.138x | -129.30% |
| 2017-12-31 | Skr13.41 Million | Skr6.33 Million | 0.472x | +153.22% |
| 2016-12-31 | Skr22.11 Million | Skr-19.60 Million | -0.886x | -19.15% |
| 2015-12-31 | Skr13.06 Million | Skr-9.71 Million | -0.744x | -482.81% |
| 2014-12-31 | Skr-3.11 Million | Skr-604.49K | 0.194x | -- |